SGS
Sterling Global Strategies’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $266K | Hold |
3,000
| – | – | 1.48% | 18 |
|
|
2018
Q4 | $255K | Hold |
3,000
| – | – | 1.3% | 16 |
|
|
2018
Q3 | $291K | Hold |
3,000
| – | – | 1.27% | 20 |
|
|
2018
Q2 | $283K | Hold |
3,000
| – | – | 1.83% | 16 |
|
|
2018
Q1 | $243K | Hold |
3,000
| – | – | 1.14% | 22 |
|
|
2017
Q4 | $268K | Hold |
3,000
| – | – | 1.13% | 21 |
|
|
2017
Q3 | $279K | Hold |
3,000
| – | – | 1.14% | 24 |
|
|
2017
Q2 | $272K | Hold |
3,000
| – | – | 1.3% | 20 |
|
|
2017
Q1 | $263K | Hold |
3,000
| – | – | 1.27% | 19 |
|
|
2016
Q4 | $249K | Hold |
3,000
| – | – | 1.01% | 19 |
|
|
2016
Q3 | $278K | Hold |
3,000
| – | – | 1.03% | 18 |
|
|
2016
Q2 | $233K | Hold |
3,000
| – | – | 0.89% | 17 |
|
|
2016
Q1 | $247K | Hold |
3,000
| – | – | 1.26% | 16 |
|
|
2015
Q4 | $314K | Hold |
3,000
| – | – | 4.98% | 8 |
|
|
2015
Q3 | $316K | Hold |
3,000
| – | – | 1.74% | 9 |
|
|
2015
Q2 | $410K | Hold |
3,000
| – | – | 1.38% | 8 |
|
|
2015
Q1 | $374K | Hold |
3,000
| – | – | 1.14% | 11 |
|
|
2014
Q4 | $271K | Buy |
+3,000
| New | +$271K | 0.15% | 14 |
|